Vimarsana
Biggest News Aggregation in the World

Left Ventricular News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Left Ventricular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Left Ventricular Today - Breaking & Trending Today

Left Appendage Occlusion Device Market Closing the Gap on Stroke - Vimarsana News

Left Appendage Occlusion Device Market Closing the Gap on Stroke

Press release - InsightAce Analytic Pvt.Ltd - Left Appendage Occlusion Device Market Closing the Gap on Stroke Risk: The Left Atrial Appendage Occlusion Device - published on openPR.com

Source: openpr.com
Direct Oral Anticoagulant Use for Left Ventricular Thrombus Treatment - Vimarsana News

Direct Oral Anticoagulant Use for Left Ventricular Thrombus Treatment

An overview of the use of direct oral anticoagulants as an alternative to warfarin in the treatment of left ventricular thrombus.

Coronary Artery Bypass Grafting (CABG) | Coronary Artery Bypass Surgery - Vimarsana News

Coronary Artery Bypass Grafting (CABG) | Coronary Artery Bypass Surgery

Coronary artery bypass grafting (CABG) or heart bypass surgery is an open heart surgery to relieve the blockages of the arteries of the heart. Coronary artery bypass surgery lasts up to 3 to 6 hours.

Echocardiography Boosts Prognostic Power in T1D - Vimarsana News

Echocardiography Boosts Prognostic Power in T1D

Myocardial performance index, a heart-function metric derived from echo findings, significantly boosted the ability to predict incident CVD, especially heart failure, in people with type 1 diabetes.

Rocket Pharmaceuticals Reaches FDA Alignment on Pivotal Phase 2 Trial Design for RP-A501 in Danon Di - Vimarsana News

Rocket Pharmaceuticals Reaches FDA Alignment on Pivotal Phase 2 Trial Design for RP-A501 in Danon Di

Final alignment reached on a 12 patient, single-arm, open label study with a biomarker based co-primary endpoint assessed at 12 months to support accelerated approvalCo-primary endpoint consisting of LAMP2 protein expression and Left Ventricular (LV) Mass change from baselineCRANBURY, N.J.--(BUSINESS WIRE)--Rocket P...